中国医药: 第九届董事会第29次会议决议公告

Meeting Overview - The 29th meeting of the 9th Board of Directors of China National Pharmaceutical Group Co., Ltd. was held on July 23, 2025, combining in-person and communication methods, chaired by Chairman Yang Guang [1] - All 7 directors attended the meeting, confirming compliance with the Company Law and Articles of Association, making the resolutions valid [1] Resolutions Passed - The board approved the establishment of a "Market Value Management System" [2] - The board agreed to set up a Health and E-commerce Division and adjust internal structures [2] - The board approved an increase in the estimated guarantee limit for 2025 [2] - The board appointed Yang Guang as the General Manager, effective until the end of the 9th Board's term [2][3] - The board appointed Zhang Peng and Chen Jianxiong as Deputy General Managers, effective until the end of the 9th Board's term [3] - The board approved the convening of the 5th Extraordinary General Meeting of Shareholders in 2025 [3]